2003 WHA on global health-sector strategy for HIV/AIDS

56th WHA
28 May 2003

Analysis of precedential value

The World Health Assem­bly is the deci­sion-mak­ing body of the World Health Orga­ni­za­tion. It includes del­e­ga­tions from every UN mem­ber state, which gather annu­ally to address ques­tions about WHO’s gov­er­nance, bud­get, and progress. Although WHA res­o­lu­tions are cen­tred on health, they engage var­i­ous related top­ics rang­ing from mil­i­tary aggres­sion to migrant rights.

Used as precedent

access to health products

Exhorts Mem­ber States, as a mat­ter of urgency to reaf­firm that pub­lic health inter­ests are para­mount in both phar­ma­ceu­ti­cal and health poli­cies, to rec­og­nize the dif­fi­cul­ties faced by devel­op­ing coun­tries in effec­tive use of com­pul­sory licens­ing in accor­dance with the Dec­la­ra­tion on the TRIPS Agree­ment and Pub­lic Health (Doha Dec­la­ra­tion), and, when nec­es­sary, to use the flex­i­bil­i­ties in the TRIPS Agree­ment in order to meet the needs of devel­op­ing coun­tries for drugs against HIV/AIDS.